乱用薬物（DOA）検査の世界市場：2034年までの機会と戦略

乱用薬物（DOA）検査の世界市場は2019年に53億9,340万米ドルと評価され、2024年までCAGR6.00％以上で成長しました。

薬物乱用事例の増加

歴史的な期間における乱用薬物検査市場の成長は、薬物乱用事例の増加によって牽引されてきました。薬物乱用事例とは、個人が違法薬物、処方薬、その他の有害物質などの物質を過剰に、または不適切に使用し、身体的、心理的、または社会的危害につながる状況を指します。薬物乱用事件の増加は、しばしば精神衛生問題の深刻化と関連しており、多くの個人が不安、抑うつ、感情的苦痛などの状態に対処するために、オピオイドや大麻などの物質に頼っているからです。乱用薬物検査の需要は、安全性、コンプライアンス、公衆衛生を維持するために、雇用主、ヘルスケアプロバイダー、法執行機関、教育機関が物質の誤用を監視、検出、防止する必要性によって推進されています。例えば、英国の政府機関である国家統計局によると、2023年3月末までの1年間に薬物を使用したと報告したのは、16歳から59歳の個人の約9.5％（約310万人）でした。そのうち7.6％（約250万人）が大麻の使用を報告し、3.3％（約110万人）がA級薬物の使用を報告しています。したがって、薬物乱用事例の増加は、乱用薬物検査市場の拡大に大きく寄与しています。

目次

第1章 エグゼクティブサマリー

• 乱用薬物（DOA）検査-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

• 一般的な市場の定義
• 概要
• 乱用薬物（DOA）検査市場定義とセグメンテーション
• 市場セグメンテーション：製品とサービス別
  • 分析器
  • 迅速検査装置
  • 消耗品
  • ラボサービス
• 市場セグメンテーション：サンプルタイプ別
  • 尿
  • 髪
  • 口腔液
  • 呼吸
  • その他のサンプルタイプ
• 市場セグメンテーション：用途別
  • 疼痛管理
  • 刑事司法
  • 職場スクリーニング
• 市場セグメンテーション：エンドユーザー別
  • 病院
  • 診断検査室
  • 法医学研究所
  • その他のエンドユーザー

第7章 主要な市場動向

• 質量分析ソリューションで薬物検査に革命を起こし、精度と効率を向上
• 革新的な薬物乱用試薬が検査の精度と携帯性を向上させる
• 尿中薬物乱用検査の精度向上と迅速検出の拡大

第8章 世界の乱用薬物（DOA）検査の成長分析と戦略分析フレームワーク

• 世界の乱用薬物（DOA）検査のPESTEL分析（政治、社会、技術、環境、法的要因）
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 環境
  • 法律上
• エンドユーザー分析（B2B）
  • 病院
  • 診断検査室
  • 法医学研究所
  • その他のエンドユーザー
• 世界の乱用薬物（DOA）検査市場：成長率分析
• 市場成長実績, 2019-2024
  • 市場促進要因2019年～2024年
  • 市場抑制要因2019年-2024年
• 市場成長予測, 2024-2029, 2034F
  • 市場促進要因2024年～2029年
  • 市場抑制要因2024年～2029年
• 成長予測の貢献要因
  • 量的成長の貢献者
  • 促進要因
  • 抑制要因
• 世界の乱用薬物（DOA）検査の有効市場規模（TAM）

第9章 世界の乱用薬物（DOA）検査市場：セグメンテーション

• 世界の乱用薬物（DOA）検査市場：製品とサービス別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場：サンプルタイプ別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場：用途別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場：エンドユーザー別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場、分析装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場、迅速検査装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場、消耗品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場、検査サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F

第10章 乱用薬物（DOA）検査市場：地域・国別分析

• 世界の乱用薬物（DOA）検査市場：地域別、実績と予測, 2019-2024, 2029F, 2034F
• 世界の乱用薬物（DOA）検査市場：国別、実績と予測, 2019-2024, 2029F, 2034F

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

• 企業プロファイル
• Abbott Laboratories
• Danaher Corporation（Beckman Coulter）
• Laboratory Corporation of America Holdings
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.

第19章 その他の大手企業と革新的企業

• F. Hoffmann-La Roche Ltd.
• Dragerwerk AG & Co. KGaA
• Siemens Healthneers
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• HireRight Holdings Corporation.
• Sonic Healthcare Limited
• LGC Limited
• DISA Global Solutions Inc.
• Randox Laboratories Ltd.
• Intoximeters Inc.
• First Advantage Corporation
• Cordant Health Solutions
• Precision Diagnostics LLC
• Omega Laboratories Inc.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

• Premier Biotech Inc., Acquired Desert Tox LLC
• Aegis Sciences Corporation Acquires Healthtrackrx's Toxicology Business

第23章 薬物乱用検査市場の最近の動向

第24章 機会と戦略

• 世界の乱用薬物（DOA）検査市場2029：新たな機会を提供する国
• 世界の乱用薬物（DOA）検査市場2029：新たな機会を提供するセグメント
• 世界の乱用薬物（DOA）検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第25章 乱用薬物（DOA）検査市場：結論と提言

• 結論
• 提言
  • 製品
  • 場所
  • 価格
  • プロモーション
  • 人々

第26章 付録

Drugs of Abuse (DOA) testing refers to the process of detecting the presence of illicit substances or misused prescription medications in an individual's system. This testing is utilized by various entities, including employers, law enforcement agencies, healthcare providers and educational institutions, to ensure safety, compliance with regulations and to provide appropriate medical interventions.

The drugs of abuse (DOA) testing market consists of sales, by entities (organizations, sole traders, or partnerships), of drugs of abuse (DOA) testing software and services used in workplaces, law enforcement, healthcare and rehabilitation programs to identify drug use, ensure compliance with regulations and support medical or legal decisions.

The global drugs of abuse (DOA) testing market was valued at $5,393.40 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Drug Abuse Cases

The growth of the drugs of abuse testing market during the historic period has been driven by the rising drug abuse cases. Drug abuse cases refer to situations where individuals excessively or improperly use substances such as illegal drugs, prescription medications, or other harmful substances, leading to physical, psychological, or social harm. Increasing drug abuse cases are often associated with escalating mental health issues, as many individuals resort to substances like opioids or cannabis to cope with conditions such as anxiety, depression, or emotional distress. The demand for drugs of abuse testing is propelled by the need for monitoring, detection, and prevention of substance misuse by employers, healthcare providers, law enforcement agencies, and educational institutions to maintain safety, compliance, and public health. For example, according to the Office for National Statistics, a UK-based government department, approximately 9.5% of individuals aged 16 to 59 years (around 3.1 million people) reported using drugs in the year ending March 2023. Among them, 7.6% reported cannabis use (around 2.5 million people), while 3.3% reported using Class A drugs (about 1.1 million people). Therefore, the increasing prevalence of drug abuse cases has significantly contributed to the expansion of the drugs of abuse testing market.

Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency

Leading companies in the drugs of abuse testing market are focusing on developing innovative solutions, such as mass spec solutions, to enhance the accuracy, sensitivity, and speed of drug testing processes. Mass Spec solution in drugs of abuse testing refers to the use of mass spectrometry (MS) technology for detecting and quantifying drugs and their metabolites in various biological samples, such as blood, urine, saliva, and hair. For instance, in December 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its cobas Mass Spec solution, which has received CE mark approval, marking a significant milestone in making clinical mass spectrometry widely available. This solution includes the cobas i 601 analyzer and the first Ionify reagent pack, enabling automated and standardized testing for over 60 analytes, including steroid hormones, vitamin D metabolites, and drugs of abuse. By integrating various technologies into a single platform, Roche aims to enhance diagnostic accuracy and efficiency in routine laboratories, facilitating earlier detection of therapeutic changes in patients. The cobas Mass Spec solution is expected to transform clinical diagnostics by providing faster, more precise results, ultimately improving patient care worldwide.

The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023.

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product and service, by sample type, by application and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product and service, by sample type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market- Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments- Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for drugs of abuse (DOA) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
• Markets Covered:
• 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
• 2) By Sample Type: Urine; Hair; Oral Fluid; Breath; Other Sample Types
• 3) By Application: Pain Management; Criminal Justice; Workplace Screening
• 4) By End User: Hospitals; Diagnostics Laboratories; Forensic Laboratories; Other End Users
• Companies Mentioned: Abbott Laboratories; Danaher Corporation (Beckman Coulter); Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Thermo Fisher Scientific Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drugs of abuse (DOA) testing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Drugs Of Abuse (DOA) Testing - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Drugs Of Abuse (DOA) Testing Market Definition And Segmentations
• 6.4 Market Segmentation By Product And Service
  • 6.4.1 Analyzers
  • 6.4.2 Rapid Testing Devices
  • 6.4.3 Consumables
  • 6.4.4 Laboratory Services
• 6.5 Market Segmentation By Sample Type
  • 6.5.1 Urine
  • 6.5.2 Hair
  • 6.5.3 Oral Fluid
  • 6.5.4 Breath
  • 6.5.5 Other Sample Types
• 6.6 Market Segmentation By Application
  • 6.6.1 Pain Management
  • 6.6.2 Criminal Justice
  • 6.6.3 Workplace Screening
• 6.7 Market Segmentation By End-User
  • 6.7.1 Hospitals
  • 6.7.2 Diagnostic Laboratories
  • 6.7.3 Forensic Laboratories
  • 6.7.4 Other End-Users

7 Major Market Trends

• 7.1 Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency
• 7.2 Innovative Drugs Of Abuse Reagents Enhance Accuracy And Portability In Testing
• 7.3 Expansion Of Urine Drugs Of Abuse Testing For Enhanced Accuracy And Rapid Detection

8 Global Drugs Of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

• 8.1 Global Drugs Of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End-Users (B2B)
  • 8.2.1 Hospitals
  • 8.2.2 Diagnostic Laboratories
  • 8.2.3 Forensic Laboratories
  • 8.2.4 Other End-Users
• 8.3 Global Drugs Of Abuse (DOA) Testing Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.2 Market Restraints 2019 - 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.5.1 Market Drivers 2024 - 2029
  • 8.5.2 Market Restraints 2024 - 2029
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global Drugs Of Abuse (DOA) Testing Total Addressable Market (TAM)

9 Global Drugs Of Abuse (DOA) Testing Market Segmentation

• 9.1 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.8 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Drugs Of Abuse (DOA) Testing Market, Regional and Country Analysis

• 10.1 Global Drugs Of Abuse (DOA) Testing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Drugs Of Abuse (DOA) Testing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia-Pacific Drugs Of Abuse (DOA) Testing Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Major Companies
• 11.10 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.11 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.12 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 India Market
• 11.14 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 Australia Market
• 11.24 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.25 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.26 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 Indonesia Market
• 11.28 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.30 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 South Korea Market
• 11.32 Summary
• 11.33 Market Overview
  • 11.33.1 Country Information
  • 11.33.2 Market Information
  • 11.33.3 Background Information
  • 11.33.4 Government Initiatives
  • 11.33.5 Regulations
  • 11.33.6 Regulatory Bodies
  • 11.33.7 Major Associations
  • 11.33.8 Taxes Levied
  • 11.33.9 Corporate Tax Structure
  • 11.33.10 Major Companies
• 11.34 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 Western Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
• 12.7 UK Market
• 12.8 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 Germany Market
• 12.12 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 France Market
• 12.16 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Italy Market
• 12.20 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Spain Market
• 12.24 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Major companies
• 13.3 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Eastern Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
• 13.7 Russia Market
• 13.8 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.10 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 North America Drugs Of Abuse (DOA) Testing Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.11 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.12 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Investments
  • 14.15.11 Major Companies
• 14.16 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.18 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 South America Drugs Of Abuse (DOA) Testing Market: Country Analysis
• 15.7 Brazil Market
• 15.8 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.10 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Abbott Laboratories
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Financial Overview
• 18.3 Danaher Corporation (Beckman Coulter)
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 Laboratory Corporation of America Holdings
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Financial Overview
• 18.5 Quest Diagnostics Inc.
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Thermo Fisher Scientific Inc.
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Business Strategy
  • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

• 19.1 F. Hoffmann-La Roche Ltd.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Dragerwerk AG & Co. KGaA
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Siemens Healthneers
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Bio-Rad Laboratories Inc.
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Agilent Technologies Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 HireRight Holdings Corporation.
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Sonic Healthcare Limited
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 LGC Limited
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 DISA Global Solutions Inc.
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Randox Laboratories Ltd.
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Intoximeters Inc.
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 First Advantage Corporation
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 Cordant Health Solutions
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 Precision Diagnostics LLC
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 Omega Laboratories Inc.
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Premier Biotech Inc., Acquired Desert Tox LLC
• 22.2 Aegis Sciences Corporation Acquires Healthtrackrx's Toxicology Business

23 Recent Developments in the Drugs of Abuse Testing Market

• 23.1 Dual Blood Marker Test Launched For Enhanced Alcohol Monitoring

24 Opportunities And Strategies

• 24.1 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Drugs Of Abuse (DOA) Testing Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer